Psychiatry investigation

Korean Neuropsychiatric Association (대한신경정신의학회)
권호 표지
DOI QR코드

DOI QR Code

A Pilot Examination of Oxidative Stress in Trichotillomania

  • Grant, Jon E. (Department of Psychiatry & Behavioral Neuroscience, University of Chicago) ;
  • Chamberlain, Samuel R. (Department of Psychiatry, University of Cambridge)
  • Received : 2018.04.30
  • Accepted : 2018.09.07
  • Published : 2018.12.31
⟨ Previous Next ⟩

Abstract

Objective Trichotillomania is a relatively common illness whose neurobiology is poorly understood. One treatment for adult trichotillomania, n-acetyl cysteine (NAC), has antioxidative properties, as well as effects on central glutamatergic transmission. Preclinical models suggest that excessive oxidative stress may be involved in its pathophysiology. Methods Adults with trichotillomania provided a blood sample for analysis of compounds that may be influenced by oxidative stress [glutathione, angiotensin II, ferritin, iron, glucose, insulin and insulin growth factor 1 (IGF1), and hepcidin]. Participants were examined on symptom severity, disability, and impulsivity. The number of participants with out-of-reference range oxidative stress measures were compared against the null distribution. Correlations between oxidative stress markers and clinical measures were examined. Results Of 14 participants (mean age 31.2 years; 92.9% female), 35.7% (n=5) had total glutathione levels below the reference range (p=0.041). Other oxidative stress measures did not have significant proportions outside the reference ranges. Lower levels of glutathione correlated significantly with higher motor impulsiveness (Barratt Impulsiveness Scale sub-score) (r=0.97, p=0.001). Conclusion A third of patients with trichotillomania had low levels of glutathione, and lower levels of glutathione correlated significantly with higher motor impulsiveness. Because NAC is a precursor for cysteine, and cysteine is a rate limiting step for glutathione production, these results may shed light on the mechanisms through which NAC can have beneficial effects for impulsive symptoms. Confirmation of these results requires a suitable larger follow-up study, including an internal normative control group.

Keywords

References

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th Ed, Text Revision. Washington D.C.: American Psychiatric Press; 2013.
  2. Grant JE, Chamberlain SR. Trichotillomania. Am J Psychiatry 2016;173: 868-874. https://doi.org/10.1176/appi.ajp.2016.15111432
  3. Camilla d'Angelo LS, Eagle DM, Grant JE, Fineberg NA, Robbins TW, Chamberlain SR. Animal models of obsessive-compulsive spectrum disorders. CNS Spectr 2014;19:28-49. https://doi.org/10.1017/S1092852913000564
  4. Grant JE, Odlaug BL, Kim SW. N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study. Arch Gen Psychiatry 2009;66:756-763. https://doi.org/10.1001/archgenpsychiatry.2009.60
  5. Bloch MH, Panza KE, Grant JE, Pittenger C, Leckman JF. N-Acetylcysteine in the treatment of pediatric trichotillomania: a randomized, double-blind, placebo-controlled add-on trial. J Am Acad Child Adolesc Psychiatry 2013;52:231-240. https://doi.org/10.1016/j.jaac.2012.12.020
  6. Grant JE, Chamberlain SR, Redden SA, Leppink EW, Odlaug BL, Kim SW. N-Acetylcysteine in the treatment of excoriation disorder: a randomized clinical trial. JAMA Psychiatry 2016;73:490-496. https://doi.org/10.1001/jamapsychiatry.2016.0060
  7. Kupchik YM, Moussawi K, Tang XC, Wang X, Kalivas BC, Kolokithas R, et al. The effect of N-acetylcysteine in the nucleus accumbens on neurotransmission and relapse to cocaine. Biol Psychiatry 2012;7:978-986.
  8. Schmaal L, Veltman DJ, Nederveen A, van den Brink W, Goudriaan AE. N-acetylcysteine normalizes glutamate levels in cocaine-dependent patients: a randomized crossover magnetic resonance spectroscopy study. Neuropsychopharmacology 2012;37:2143-2152. https://doi.org/10.1038/npp.2012.66
  9. Spencer S, Kalivas PW. Glutamate transport: a new bench to bedside mechanism for treating drug abuse. Int J Neuropsychopharmacol 2017;20:797-812. https://doi.org/10.1093/ijnp/pyx050
  10. Garner JP, Weisker SM, Dufour B, Mench JA. Barbering (fur and whisker trimming) by laboratory mice as a model of human trichotillomania and obsessive-compulsive spectrum disorders. Comp Med 2004;54:216-224.
  11. Vieira GLT, Lossie AC, Lay DC Jr, Radcliffe JS, Garner JP. Preventing, treating, and predicting barbering: a fundamental role for biomarkers of oxidative stress in a mouse model of Trichotillomania. PLoS One 2017;12:e0175222. https://doi.org/10.1371/journal.pone.0175222
  12. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(Suppl 20):22-33;quiz 34-57.
  13. Amin SN, El-Aidi AA, Zickri MB, Rashed LA, Hassan SS. Hepatoprotective effect of blocking N-methyl-d-aspartate receptors in male albino rats exposed to acute and repeated restraint stress. Can J Physiol Pharmacol 2017;95:721-731. https://doi.org/10.1139/cjpp-2016-0556
  14. Keuthen NJ, O'Sullivan RL, Ricciardi JN, Shera D, Savage CR, Borgmann AS, et al. The Massachusetts General Hospital (MGH) Hairpulling Scale: 1. development and factor analyses. Psychother Psychosom 1995;64:141-145. https://doi.org/10.1159/000289003
  15. O'Sullivan RL, Keuthen NJ, Hayday CF, Ricciardi JN, Buttolph ML, Jenike MA, et al. The Massachusetts General Hospital (MGH) Hairpulling Scale: 2. reliability and validity. Psychother Psychosom 1995;64:146-148. https://doi.org/10.1159/000289004
  16. Sheehan DV, Harnett-Sheehan K, Raj BA. The measurement of disability. Int Clin Psychopharmacol 1996;11(Suppl 3):89-95.
  17. Stanford MS, Mathias CW, Dougherty DM, Lake SL, Anderson NE, Patton JH. Fifty years of the Barratt Impulsiveness Scale: an update and review. Pers Individ Dif 2016;47:385-395.
  18. Nucifora LG, Tanaka T, Hayes LN, Kim M, Lee BJ, Matsuda T, et al. Reduction of plasma glutathione in psychosis associated with schizophrenia and bipolar disorder in translational psychiatry. Transl Psychiatry 2017;7:e1215. https://doi.org/10.1038/tp.2017.178
  19. Sansone RA, Sansone LA. Getting a Knack for NAC: N-Acetyl-Cysteine. Innov Clin Neurosci 2011;8:10-14.
  20. Guldenpfennig M, Wolmarans de W, du Preez JL, Stein DJ, Harvey BH. Cortico-striatal oxidative status, dopamine turnover and relation with stereotypy in the deer mouse. Physiol Behav 2011;103:404-411. https://doi.org/10.1016/j.physbeh.2011.03.008
  21. Brennan BP, Jensen JE, Perriello C, Pope HG Jr, Jenike MA, Hudson JI, et al. Lower posterior congulate cortex glutathione levels in obsessivecompulsive disorder. Biol Psychiatry Cogn Neurosci Neuroimaging 2016;1:116-124. https://doi.org/10.1016/j.bpsc.2015.12.003
  22. Alici D, Bulbul F, Virit O, Unal A, Altindag A, Alpak G, et al. Evaluation of oxidative metabolism and oxidative DNA damage in patients with obsessive-compulsive disorder. Psychiatry Clin Neurosci 2016;70:109-115. https://doi.org/10.1111/pcn.12362

Cited by

  1. Milk Thistle Treatment for Children and Adults with Trichotillomania : A Double-Blind, Placebo-Controlled, Crossover Negative Study vol.39, pp.2, 2018, https://doi.org/10.1097/jcp.0000000000001005
  2. Trichopsychodermatology: The Psychiatric and Psychosocial Aspects of Hair Disorders vol.33, pp.1, 2018, https://doi.org/10.1111/dth.13168
  3. Recent advances in the treatment of trichotillomania (hair‐pulling disorder) vol.33, pp.6, 2018, https://doi.org/10.1111/dth.13818